Sector Gamma As Has Decreased Ironwood Pharmaceuticals (IRWD) Holding By $8.91 Million; Mendon Capital Advisors Lifted By $1.65 Million Its Fifth Third Bancorp (Put) (FITB) Position

May 20, 2018 - By Vivian Park

Fifth Third Bancorp (NASDAQ:FITB) Logo

Mendon Capital Advisors Corp increased Fifth Third Bancorp (Put) (FITB) stake by 42.97% reported in 2017Q4 SEC filing. Mendon Capital Advisors Corp acquired 55,000 shares as Fifth Third Bancorp (Put) (FITB)’s stock rose 1.62%. The Mendon Capital Advisors Corp holds 183,000 shares with $5.55 million value, up from 128,000 last quarter. Fifth Third Bancorp (Put) now has $23.01B valuation. The stock decreased 2.19% or $0.75 during the last trading session, reaching $33.56. About 4.91M shares traded. Fifth Third Bancorp (NASDAQ:FITB) has risen 26.73% since May 20, 2017 and is uptrending. It has outperformed by 15.18% the S&P500.

Sector Gamma As decreased Ironwood Pharmaceuticals Inc (IRWD) stake by 34.87% reported in 2017Q4 SEC filing. Sector Gamma As sold 636,449 shares as Ironwood Pharmaceuticals Inc (IRWD)’s stock declined 1.30%. The Sector Gamma As holds 1.19 million shares with $17.82M value, down from 1.83 million last quarter. Ironwood Pharmaceuticals Inc now has $2.75B valuation. It closed at $18.08 lastly. It is down 11.53% since May 20, 2017 and is downtrending. It has underperformed by 23.08% the S&P500.

Since February 5, 2018, it had 0 buys, and 11 insider sales for $6.84 million activity. Hazel Mark D sold $644,747 worth of stock or 19,324 shares. Forrest Frank R. had sold 29,508 shares worth $960,780. McWilliams Jelena sold $64,436 worth of stock. Another trade for 16,485 shares valued at $530,570 was sold by ANDERSON LARS C. Another trade for 87,613 shares valued at $2.84M was made by CARMICHAEL GREG D on Tuesday, February 13. 4,000 Fifth Third Bancorp (NASDAQ:FITB) shares with value of $134,400 were sold by Immaneni Aravind. The insider Leonard James C. sold $1.18 million.

Mendon Capital Advisors Corp decreased Us Bancorp Del (Put) (NYSE:USB) stake by 70,000 shares to 122,000 valued at $6.54M in 2017Q4. It also reduced Iberiabank Corp (NASDAQ:IBKC) stake by 75,000 shares and now owns 75,000 shares. Pcsb Finl Corp was reduced too.

Among 33 analysts covering Fifth Third (NASDAQ:FITB), 6 have Buy rating, 3 Sell and 24 Hold. Therefore 18% are positive. Fifth Third had 110 analyst reports since July 22, 2015 according to SRatingsIntel. As per Friday, July 21, the company rating was maintained by Oppenheimer. The rating was maintained by Keefe Bruyette & Woods with “Hold” on Tuesday, December 12. The rating was downgraded by Goldman Sachs to “Neutral” on Friday, October 2. The company was downgraded on Friday, November 18 by Compass Point. As per Friday, December 8, the company rating was maintained by RBC Capital Markets. The firm has “Equal-Weight” rating by Morgan Stanley given on Monday, April 30. The stock of Fifth Third Bancorp (NASDAQ:FITB) has “Hold” rating given on Wednesday, August 23 by Keefe Bruyette & Woods. The stock of Fifth Third Bancorp (NASDAQ:FITB) has “Equal-Weight” rating given on Wednesday, December 13 by Morgan Stanley. The stock of Fifth Third Bancorp (NASDAQ:FITB) has “Hold” rating given on Tuesday, January 23 by Sandler O’Neill. Nomura maintained the stock with “Neutral” rating in Thursday, September 28 report.

Investors sentiment increased to 0.98 in 2017 Q4. Its up 0.33, from 0.65 in 2017Q3. It is positive, as 29 investors sold FITB shares while 210 reduced holdings. 74 funds opened positions while 161 raised stakes. 562.64 million shares or 2.26% less from 575.67 million shares in 2017Q3 were reported. 78,282 are held by Virtus Investment Advisers Inc. Acadian Asset Mgmt reported 0% in Fifth Third Bancorp (NASDAQ:FITB). First Republic Invest Mgmt invested 0.01% in Fifth Third Bancorp (NASDAQ:FITB). Blackrock accumulated 0.07% or 45.98M shares. Regions Financial Corporation stated it has 0% in Fifth Third Bancorp (NASDAQ:FITB). Menta Capital Ltd Limited Liability Company accumulated 0.29% or 49,500 shares. 4,995 were accumulated by Valley Natl Advisers Incorporated. 12,416 are owned by Wetherby Asset Mngmt. State Of Alaska Department Of Revenue holds 101,943 shares or 0.07% of its portfolio. Altrinsic Ltd Company accumulated 26,581 shares. Mountain Pacific Investment Advisers Id has invested 0.08% of its portfolio in Fifth Third Bancorp (NASDAQ:FITB). 40,000 are held by Employees Retirement System Of Texas. Norris Perne And French Ltd Liability Partnership Mi owns 0.06% invested in Fifth Third Bancorp (NASDAQ:FITB) for 13,312 shares. Panagora Asset Mngmt Inc invested in 0.14% or 1.25 million shares. Commonwealth Of Pennsylvania Public School Empls Retrmt Systems accumulated 0.03% or 63,113 shares.

More news for Fifth Third Bancorp (NASDAQ:FITB) were recently published by:, which released: “Regional banks mull threat from Amazon” on April 26, 2018.‘s article titled: “New Research Coverage Highlights Graphic Packaging Holding, Regions Financial, Devon Energy, Fifth Third, Gastar …” and published on May 10, 2018 is yet another important article.

Analysts await Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) to report earnings on August, 2. They expect $-0.18 earnings per share, up 35.71% or $0.10 from last year’s $-0.28 per share. After $-0.27 actual earnings per share reported by Ironwood Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -33.33% EPS growth.

Since January 24, 2018, it had 0 insider purchases, and 7 sales for $1.22 million activity. $21,090 worth of stock was sold by McHugh Julie on Monday, March 5. $113,483 worth of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares were sold by Gilbert Halley E. Consylman Gina sold $52,688 worth of stock. 60,000 shares were sold by Currie Mark G, worth $927,000 on Wednesday, January 24. MCCOURT Thomas A had sold 3,343 shares worth $49,008. On Monday, March 5 the insider OLANOFF LAWRENCE S sold $28,100.

Investors sentiment decreased to 1.05 in Q4 2017. Its down 0.20, from 1.25 in 2017Q3. It dropped, as 18 investors sold IRWD shares while 44 reduced holdings. 21 funds opened positions while 44 raised stakes. 149.98 million shares or 2.99% less from 154.60 million shares in 2017Q3 were reported. New York-based Bnp Paribas Arbitrage has invested 0% in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Glenmede Na holds 2,110 shares. Moreover, Grp Incorporated One Trading Lp has 0% invested in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) for 243 shares. Bank & Trust Of Montreal Can holds 0% or 58,537 shares in its portfolio. Td Asset Mngmt Inc has invested 0.01% in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Artal Gru invested in 0.12% or 516,879 shares. Susquehanna Intl Gp Llp invested 0% of its portfolio in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Price T Rowe Associate Md holds 0.04% or 17.86M shares. Ameriprise invested in 0% or 75,101 shares. Evercore Wealth Mgmt Limited Liability Corp reported 0.01% in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Alps Advisors holds 0.02% or 150,030 shares in its portfolio. First Republic Mgmt owns 0% invested in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) for 35,058 shares. Manufacturers Life Ins The invested in 0% or 103,462 shares. Park West Asset Mngmt Lc accumulated 613,958 shares or 0.42% of the stock. Clearbridge Limited Liability Com owns 0.25% invested in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) for 795,659 shares.

Among 16 analysts covering Ironwood Pharmaceuticals (NASDAQ:IRWD), 6 have Buy rating, 3 Sell and 7 Hold. Therefore 38% are positive. Ironwood Pharmaceuticals had 42 analyst reports since August 6, 2015 according to SRatingsIntel. Barclays Capital maintained Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) rating on Friday, February 19. Barclays Capital has “Equal-Weight” rating and $11 target. Bank of America downgraded the stock to “Sell” rating in Friday, January 5 report. The stock has “Buy” rating by BTIG Research on Friday, December 11. As per Friday, November 4, the company rating was maintained by Mizuho. The stock has “Buy” rating by Cowen & Co on Monday, August 21. On Thursday, April 19 the stock rating was initiated by Berenberg with “Buy”. The firm has “Neutral” rating by Wedbush given on Friday, February 19. The stock of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has “Buy” rating given on Tuesday, June 6 by Mizuho. As per Wednesday, April 6, the company rating was upgraded by Cowen & Co. Cowen & Co maintained Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) on Friday, August 4 with “Buy” rating.

More important recent Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) news were published by: which released: “Your Daily Pharma Scoop: IRWD Division, Jazz sNDA, Siga Adcomm” on May 03, 2018, also published article titled: “Morgan Stanley Turns Bearish On Ironwood Pharma, Lowers Linzess Sales Estimate”, published: “Detailed Research: Economic Perspectives on CASI Pharmaceuticals, Energy Transfer Partners, Cypress …” on May 07, 2018. More interesting news about Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) was released by: and their article: “Premarket analyst action – healthcare” with publication date: May 09, 2018.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News